Business & Finance
AstraZeneca to buy Fusion Pharma for $2 billion in cash
AstraZeneca said on Tuesday it will buy clinical-stage biopharmaceutical company Fusion Pharmaceuticals Inc for...
Subscribing is the best way to get our best stories immediately.